瑞普生物(300119.SZ)：公司目前无尼帕病毒相关的针对性疫苗、药品

Core Viewpoint - The company, Reap Bio (300119.SZ), currently does not have any targeted vaccines or drugs related to the Nipah virus and will continue to monitor the virus dynamics to assess research and development opportunities [1] Company Summary - Reap Bio has stated that it is not involved in the development of any Nipah virus-related vaccines or treatments at this time [1] - The company emphasizes its commitment to keeping an eye on the developments related to the Nipah virus [1] - Future research and development opportunities will be evaluated based on the ongoing situation of the virus [1]